AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Wonride M 0.5 Tablet SR

Prescription Icon
Prescription Required

Marketer

Wonset Healthcare Pvt Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Wonride M 0.5 Tablet SR

Diabexe Duo 0.5mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabexe Duo 0.5mg ER should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with well-managed blood sugar, as discontinuation without medical supervision risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a holistic approach encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, lightheadedness, headache, and tremors. Recognize these symptoms and carry readily-available glucose sources like sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Consult your doctor prior to use if pregnant or breastfeeding. Regular blood glucose monitoring is essential, and your physician may recommend blood tests to assess blood cell counts and liver function.

Uses of Wonride M 0.5 Tablet SR

Managing type 2 diabetes

Major Benefits of Wonride M 0.5 Tablet SR:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Wonride M 0.5mg Extended-Release Tablet with a meal.

Common Side effects of Wonride M 0.5 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Wonride M 0.5 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Wonride M 0.5 Tablet SR with a meal.

How Wonride M 0.5 Tablet SR works:

Each Wonride M 0.5 SR tablet contains glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Wonride M 0.5 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Wonride M 0.5 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Use of Wonride M 0.5 Tablet SR while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Wonride M 0.5 Tablet SR cautiously, potentially requiring a modified dosage. Physician consultation is advised. Wonride M 0.5 Tablet SR is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Wonride M 0.5 mg sustained-release tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Wonride M 0.5 Tablet SR :

Should you forget to take a Wonride M 0.5 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Wonride M 0.5 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Wonride M 0.5 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Wonride M 0.5 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Wonride M 0.5 Tablet SR and seek immediate medical attention.
Wonride M 0.5 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Wonride M 0.5 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Wonride M 0.5 Tablet SR can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, supplemental Vitamin B12 is recommended at least annually, according to some research.
Yes, Wonride M 0.5 Tablet SR can lower blood sugar, causing hypoglycemia. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Wonride M 0.5 Tablet SR and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Wonride M 0.5 Tablet SR
37
MRP 43
12% off